Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 2 AND POTASSIUM CHLORIDE 15MEQ K versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 2 AND POTASSIUM CHLORIDE 15MEQ K versus MAGNESIUM SULFATE.
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K) vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of calories and energy; sodium chloride and potassium chloride replenish electrolytes and maintain fluid balance.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion at a rate of 100-200 mL/hour (2-4 mL/kg/hour) based on fluid and electrolyte requirements. Maximum infusion rate: 1000 mL/hour. Adjust according to serum potassium levels.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Not applicable as terminal half-life for dextrose is not defined due to rapid metabolism; for potassium, distribution half-life ~1-1.5 h, terminal half-life ~12-24 h reflecting renal elimination.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Renal: glucose is completely reabsorbed under normal conditions; excess is excreted unchanged in urine. Sodium, chloride, and potassium are primarily excreted renally, with >90% of infused loads eliminated by kidneys. Fecal and biliary excretion are negligible.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte